FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2568210207> ?p ?o ?g. }

• W2568210207 endingPage "295" @default.
• W2568210207 startingPage "284" @default.
• W2568210207 abstract "New drugs are urgently needed for the treatment of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). The aim of this meta-analysis was to evaluate the efficacy and safety of glucagon-like peptide-1 receptor agonists (GLP-1RAs) in NAFLD/NASH.We searched the MEDLINE, Embase, and Cochrane Library Central to identify randomized controlled trials (RCTs) and observational studies that compared GLP-1RAs with a control treatment or baseline values with respect to efficacy and safety in patients with NAFLD/NASH. Mean differences (MDs) with 95% confidence intervals (CIs) and odds ratios (ORs) were pooled using a random-effect model.Six studies were eligible and included. Among the 329 NAFLD/NASH patients included in these studies, 277 patients had type 2 diabetes (T2D). GLP-1RA treatment produced significant reductions relative to baseline in liver histology scores for steatosis (MD, 0.80; 95% CI, 0.49 to 1.11), lobular inflammation (MD, 0.22; 95% CI, 0.00 to 0.45), hepatocellular ballooning (MD, 0.41; 95% CI, 0.15 to 0.67) and fibrosis (MD, 0.35; 95% CI, 0.00 to 0.70). Compared with placebo and positive agents, GLP-1RAs significantly reduced gamma-glutamyl transpeptidase (GGT) levels (MD, 13.8 U/L; 95% CI, 7.4 to 20.3; P<0.001). The reported major adverse events associated with GLP-1RA treatment included mild to moderate gastrointestinal discomfort that resolved within a few weeks.Our study suggests that in NASH patients, particularly patients with diabetes, GLP-1RAs may improve liver histology and reduce aminotransferase levels from baseline. Benefits of GLP-1RAs are considered to outweigh the risks in NAFLD/NASH patients with or without diabetes." @default.
• W2568210207 created "2017-01-13" @default.
• W2568210207 creator A5002005546 @default.
• W2568210207 creator A5030908494 @default.
• W2568210207 creator A5052224883 @default.
• W2568210207 creator A5064711465 @default.
• W2568210207 creator A5067326635 @default.
• W2568210207 creator A5067669095 @default.
• W2568210207 creator A5069340971 @default.
• W2568210207 creator A5072861069 @default.
• W2568210207 creator A5091607881 @default.
• W2568210207 date "2017-06-01" @default.
• W2568210207 modified "2023-10-16" @default.
• W2568210207 title "Efficacy and safety of glucagon-like peptide-1 receptor agonists in non-alcoholic fatty liver disease: A systematic review and meta-analysis" @default.
• W2568210207 cites W1247968195 @default.
• W2568210207 cites W1530949477 @default.
• W2568210207 cites W1539916041 @default.
• W2568210207 cites W1551039124 @default.
• W2568210207 cites W1622799587 @default.
• W2568210207 cites W1758829516 @default.
• W2568210207 cites W1856151485 @default.
• W2568210207 cites W1866142084 @default.
• W2568210207 cites W1895758276 @default.
• W2568210207 cites W1922087192 @default.
• W2568210207 cites W1966379378 @default.
• W2568210207 cites W1968002849 @default.
• W2568210207 cites W1969295126 @default.
• W2568210207 cites W1969489686 @default.
• W2568210207 cites W1972705115 @default.
• W2568210207 cites W1983616459 @default.
• W2568210207 cites W1987727907 @default.
• W2568210207 cites W1990055069 @default.
• W2568210207 cites W1997425045 @default.
• W2568210207 cites W2002349285 @default.
• W2568210207 cites W2004409542 @default.
• W2568210207 cites W2005638869 @default.
• W2568210207 cites W2020816546 @default.
• W2568210207 cites W2045084840 @default.
• W2568210207 cites W2045923887 @default.
• W2568210207 cites W2058922633 @default.
• W2568210207 cites W2062812115 @default.
• W2568210207 cites W2069412892 @default.
• W2568210207 cites W2070070132 @default.
• W2568210207 cites W2074203821 @default.
• W2568210207 cites W2078519195 @default.
• W2568210207 cites W2086177834 @default.
• W2568210207 cites W2097677758 @default.
• W2568210207 cites W2098689751 @default.
• W2568210207 cites W2103156933 @default.
• W2568210207 cites W2106061083 @default.
• W2568210207 cites W2112981414 @default.
• W2568210207 cites W2113064802 @default.
• W2568210207 cites W2113983413 @default.
• W2568210207 cites W2116475791 @default.
• W2568210207 cites W2120056458 @default.
• W2568210207 cites W2125769789 @default.
• W2568210207 cites W2127125241 @default.
• W2568210207 cites W2131490500 @default.
• W2568210207 cites W2138748324 @default.
• W2568210207 cites W2139351004 @default.
• W2568210207 cites W2140068099 @default.
• W2568210207 cites W2145662952 @default.
• W2568210207 cites W2152835319 @default.
• W2568210207 cites W2154075360 @default.
• W2568210207 cites W2157671355 @default.
• W2568210207 cites W2158666727 @default.
• W2568210207 cites W2168763055 @default.
• W2568210207 cites W2215535790 @default.
• W2568210207 cites W2329117883 @default.
• W2568210207 cites W2358863574 @default.
• W2568210207 cites W2432078508 @default.
• W2568210207 cites W2468996569 @default.
• W2568210207 cites W2530056715 @default.
• W2568210207 cites W2615637571 @default.
• W2568210207 cites W2616752079 @default.
• W2568210207 cites W807162506 @default.
• W2568210207 doi "https://doi.org/10.1016/j.clinre.2016.11.009" @default.
• W2568210207 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28065744" @default.
• W2568210207 hasPublicationYear "2017" @default.
• W2568210207 type Work @default.
• W2568210207 sameAs 2568210207 @default.
• W2568210207 citedByCount "53" @default.
• W2568210207 countsByYear W25682102072017 @default.
• W2568210207 countsByYear W25682102072018 @default.
• W2568210207 countsByYear W25682102072019 @default.
• W2568210207 countsByYear W25682102072020 @default.
• W2568210207 countsByYear W25682102072021 @default.
• W2568210207 countsByYear W25682102072022 @default.
• W2568210207 countsByYear W25682102072023 @default.
• W2568210207 crossrefType "journal-article" @default.
• W2568210207 hasAuthorship W2568210207A5002005546 @default.
• W2568210207 hasAuthorship W2568210207A5030908494 @default.
• W2568210207 hasAuthorship W2568210207A5052224883 @default.
• W2568210207 hasAuthorship W2568210207A5064711465 @default.
• W2568210207 hasAuthorship W2568210207A5067326635 @default.
• W2568210207 hasAuthorship W2568210207A5067669095 @default.
• W2568210207 hasAuthorship W2568210207A5069340971 @default.
• W2568210207 hasAuthorship W2568210207A5072861069 @default.

• next